Highest-materiality recent filing
UnitedHealth Q1 EPS $6.90; FY guidance raised; Alegeus deal, $2B buyback
Q1 revenues $111.7B (+2% YoY); GAAP EPS $6.90, adjusted $7.23.
UNH 2025 rev $447.6B (+12%), adj EPS $16.35; 2026 outlook adj EPS >$17.75
Full year 2025 GAAP EPS $13.23, adjusted EPS $16.35 (down from 2024); Q4 adjusted EPS $2.11 vs $0.01 GAAP.
UnitedHealth Q3 EPS $2.59 ($2.92 adj); rev $113.2B +12%; raises FY25 outlook to ≥$16.25 adj
GAAP EPS $2.59, adjusted EPS $2.92; net margin 2.1% vs 6.0% a year ago.
UnitedHealth appoints Wayne DeVeydt as CFO effective Sept 2; John Rex becomes strategic advisor
Wayne S. DeVeydt named CFO effective Sept 2, 2025; replaces John F. Rex who becomes strategic advisor.
UnitedHealth Q2 EPS $3.74, cuts FY outlook; cites $1.2B unfavorable items, high medical trend
Q2 revenue $111.6B (+13% YoY); diluted EPS $3.74; adjusted EPS $4.08.
UnitedHealth Group discloses DOJ criminal and civil investigations into Medicare program
Company proactively contacted DOJ after media reports; now complying with formal criminal and civil requests.
CEO Witty steps down; Hemsley returns; 2025 outlook suspended on higher medical costs
Andrew Witty resigns as CEO effective May 12, 2025, for personal reasons; stays as senior advisor.
UnitedHealth Q1 adj EPS $7.20 misses; revises FY2025 guidance down to $26-$26.50 adj EPS
Q1 EPS $6.85 ($7.20 adjusted); revenues $109.6B, up $9.8B YoY.
UnitedHealth Group Reports 2024 Revenues of $400.3 Billion, Up 8%, and Affirms 2025 Outlook
Full year 2024 revenues grew 8% to $400.3 billion, with Q4 revenues of $100.8 billion.
UnitedHealth Group announces death of UnitedHealthcare CEO Brian Thompson
Brian Thompson, CEO of UnitedHealthcare, passed away on December 4, 2024.
UnitedHealth Group issues 2025 guidance: rev $450-455B, adj EPS $29.50-30.00
2025 revenue expected $450B–$455B; 2025 adjusted EPS $29.50–$30.00.
UnitedHealth Q3 revenue $100.8B (+9.2% YoY); adj EPS $7.15; MCR 85.2% vs 82.3%
GAAP EPS $6.51 includes $0.28 direct cyberattack response costs; adjusted EPS $7.15 includes $0.12 business disruption.
UnitedHealth Q2 rev $98.9B, adj. EPS $6.80; cyber costs $0.92; reaffirms FY adj. outlook
Q2 GAAP EPS $4.54 includes $1.28 South America charge and $0.92 cyber impacts; adjusted EPS $6.80.
UnitedHealth Group: Change Healthcare Cyberattack Data Review Ongoing, 80% of Functionality Restored
Data sampling found files containing PHI or PII that could cover a substantial proportion of people in America; no evidence of full medical histories exfiltrated.
UnitedHealth Q1 net loss $1.53/shr on Brazil sale and cyberattack; adj EPS $6.91, revenue $99.8B
Q1 revenue $99.8B (+$8B YoY); net loss per share $1.53 includes $7B Brazil charge and $0.74 cyberattack impact.
UnitedHealth Group provides timeline for restoring Change Healthcare systems after cyberattack
Pharmacy e-prescribing fully functional; claim submission/payment transmission available as of March 7.
UnitedHealth reports cyber breach at Change Healthcare by suspected nation-state actor
Suspected nation-state threat actor gained access to Change Healthcare IT systems on Feb 21, 2024.
UnitedHealth FY2023 rev $371.6B (+15%), adj EPS $25.12; Q4 adj EPS $6.16; affirms 2024 outlook
Full-year revenues $371.6B (+14.6% YoY); earnings from operations $32.4B (+13.8%).
UnitedHealth to sell Brazil operations; expects ~$7B charge, confirms adjusted EPS view
Agreed to sell Brazil operations to a private investor; expected close H1 2024 subject to regulatory conditions.
UnitedHealth Group issues 2024 guidance: revenue $400B-$403B, adjusted EPS $27.50-$28.00
2024 revenue guidance $400B-$403B; adjusted net earnings $27.50-$28.00 per share.
UnitedHealth Q3 revenue $92.4B (+14% YoY), EPS $6.24; adj. $6.56; raises FY2023 guidance
Revenue $92.4B (+14% YoY); operating earnings $8.5B (+14% YoY).
the Board of Directors of UnitedHealth Group Incorporated (the “Company”) accepted Andrew Witty’s resignation as a director of the Company, effective immediately.
On May 12, 2025, the Board of Directors of the Company (the “Board”) appointed Steve Hemsley as the Chief Executive Officer of the Company, beginning on the Effective Date.
On May 12, 2025, Andrew Witty, Chief Executive Officer of UnitedHealth Group Incorporated (the “Company”), notified the Company of his decision to step down from his position, effective May 12, 2025
Patrick Conway, M.D., currently Chief Executive Officer of Optum Rx, has been appointed to serve as Chief Executive Officer of Optum on the Effective Date.
Heather Cianfrocco, currently Chief Executive Officer of Optum, has been appointed to serve in the enterprise-wide role of Executive Vice President, Governance, Compliance and Information Security of the Company, effective May 6, 2025
Chris Zaetta, Chief Legal Officer of Optum, will succeed Mr. Bondy to assume the role of the Company’s Executive Vice President, Chief Legal Officer and Corporate Secretary on the Effective Date.
Rupert Bondy, the Company’s Executive Vice President, Chief Legal Officer and Corporate Secretary, will transition from that role to begin serving as the Company’s Senior Counsel and Executive Vice President, Governance, Compliance and Security, effective June 4, 2024
On March 28, 2024, UnitedHealth Group Incorporated (the “Company”) announced that, effective April 1, 2024, John Rex, the Company’s Chief Financial Officer, has been appointed to serve as the Company’s President in addition to continuing with his existing responsibilities as Chief Financial Officer.
On February 6, 2024, Dirk McMahon (age 64), President and Chief Operating Officer of UnitedHealth Group Incorporated (the “Company”), notified the Company of his decision to retire, effective April 1, 2024.
On November 3, 2023, UnitedHealth Group Incorporated (“the “Company”) issued a press release announcing the appointment of Charles D. Baker to serve as an independent director of the Company, effective October 30, 2023.
On December 12, 2022, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing the appointment of Kristen L. Gil to serve as an independent director of the Company, effective December 9, 2022.
UnitedHealth Group Incorporated (the “Company”) has announced that, effective February 14, 2022, Patricia L. Lewis, the Company’s Executive Vice President and Chief Human Resources Officer, transitioned from that role to begin serving as the Company’s Chief Sustainability Officer.
Max materiality 0.90 · Median 0.50 · Most common event earnings